Targeting LIM kinase in cancer and neurofibromatosis.
Department of Neurobiology; The George S. Wise Faculty of Life Sciences; Tel Aviv University; Tel Aviv, Israel.
Roni
R
Rak
Department of Neurobiology; The George S. Wise Faculty of Life Sciences; Tel Aviv University; Tel Aviv, Israel.
Yoel
Y
Kloog
D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics; D001549:Benzamides / Q000494:pharmacology*; D006801:Humans; D007555:Isoxazoles / Q000494:pharmacology*; D054461:Lim Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics; D009456:Neurofibromatosis 1 / Q000201:enzymology* / Q000235:genetics
C000597301:3-methyl-N-(3-((3-(trifluoromethyl)phenyl)carbamoyl)phenyl)isoxazole-5-carboxamide; D000970:Antineoplastic Agents; D001549:Benzamides; D007555:Isoxazoles; D054461:Lim Kinases